PCD is a result of defective OCTN2 caused by SLC22A5 mutations; this results in increased urine excretion of carnitine; carnitine deficiency in blood, tissues, and cells; and defective fatty acid oxidation (3). The gene discussed is SLC22A5; the disease is systemic primary carnitine deficiency disease.